Clinical trial
VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not…
NCT00369590 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00369590 |
|---|---|
| Title | VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide |
| Official title | Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor |
| Intervention type | Biological, Other |
| Interventions | ziv-aflibercept, pharmacological study, laboratory biomarker analysis |
| Enrollment | 58 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Oct 1, 2012 |
| First posted | Aug 29, 2006 |
| Last update posted | Oct 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: